HeiQ unveils HeiQ Skin Care – a probiotics-infused textile technology
HeiQ introduces a 100% biobased and long-lasting cosmetic finishing technology for textiles to the market. The newest addition to the HeiQ portfolio harnesses the power of active probiotics and selected prebiotics to enhance the skin microbiome, turning the human’s largest organ…
Viriom’s Single Pill Influenza Treatment Completes Critical Phase I Clinical Trials
Viriom Inc., dedicated to advancing a pipeline of highly effective and broadly affordable treatments targeting infectious and malignant diseases globally, announces the successful completion and positive results of Phase I clinical trial for AV5124, a novel inhibitor of influenza virus…
Bioforum Expands Clinical Trial Technology and Services with Acquisition of Validify
Bioforum, a data-focused, technology-driven CRO, today announced the acquisition of Validify (Applato Systems Ltd.), a leader in the automation of computer systems validation (CSV). With this expansion, Bioforum is addressing the growing demand for proven technology solutions to digitize and automate CSV,…
Women-led health and biotech companies dominate FACIT’s latest investments
On the globally-recognized Women’s Entrepreneurship Day, FACIT is pleased to announce investments in four breakthrough oncology innovations – all driven by women leaders. November 19th each year is a day to celebrate and showcase women’s contributions to advance communities and to strengthen…
Alo Expands Avance Care Presence with Addition of Durham Family Medicine
Alo, the North Carolina-based healthcare company founded to support independent providers and help them maintain their independence, is continuing its growth by adding Durham Family Medicine to its lineup of primary care practices operating under the Avance Care banner. The addition…
Glenpool Dentist, Dr. W. Scott White, Celebrates 20 Years of Excellence in Dentistry
Glenpool dentist, Dr. W. Scott White, is proud to announce the celebration of his 20th anniversary practicing dentistry in Glenpool. As a pillar of the dental community, Dr. White’s unwavering commitment to providing exceptional dental care has made a profound impact on the…
Halozyme Announces argenx Receives European Commission Approval of VYVGART® SC with ENHANZE® for Generalized Myasthenia Gravis
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that argenx received European Commission (EC) approval of VYVGART® SC (efgartigimod alfa and hyaluronidase-qvfc) co-formulated with ENHANZE® for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR)…
PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence
PostEra, a biotechnology company specializing in artificial intelligence for preclinical drug discovery, today announced a multi-target collaboration with Amgen, a leading biotechnology company. The collaboration will leverage PostEra’s AI platform, Proton, a pioneering innovation in generative chemistry and synthesis-aware design, and…
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial
VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to announce the topline results from the ACcomplisH China Phase 2 Trial in children with achondroplasia (ACH) aged 2 to 10 years. In the trial, patients dosed…
Innovative Researcher Ben Zimmerman Awarded Grant to Propel Aging-Related Research
Ben Zimmerman, Ph.D., a postdoctoral researcher investigator at the Helfgott Research Institute at the National University of Natural Medicine, has received a grant from the Medical Research Foundation (MRF) to advance the understanding of aging-related health. This grant investigates natural medicine interventions and mechanisms…
